CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction Elaborately Engineering a Self-Indicating Dual-Drug Nanoassembly for Site-Specific Photothermal-Potentiated Thrombus Penetration and Thrombolysis Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting - A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors AIM2-driven inflammasome activation in heart failure

Consensus2018 May 20;14(1):112-120.

JOURNAL:EuroIntervention. Article Link

Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club

Banning AP, Lassen JF, Burzotta F et al. Keywords: coronary bifurcation intervention; left main coronary artery disease; left main anatomy; device; technique; PCI quality; lesion preparation; implantation technique

ABSTRACT


The 2017 EuropeanBifurcationClub (EBC) meeting was held in Porto (Portugal) and allowed a multidisciplinary international faculty to review and discuss the latest data collected in the field of coronary bifurcation interventions. In particular, the topic of percutaneous coronary intervention (PCI) on left main coronary artery (LM) disease was highlighted as a contemporary priority. Herein, we summarise the key LM anatomy features, the diagnostic modalities and available data that are relevant for a patient's procedural management. Since the clinical outcomes of patients undergoing PCI on LM disease may depend on both PCI team organisation and PCI performance, the optimal catheterisation laboratory set-up and the rationales for device and technique selection are critically reviewed. The best lesion preparation modalities, the different DES implantation technique choices and the strategies to be considered during PCI on unprotected LM for optimal PCI results are reviewed step by step.